Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2026-01-08 @ 2:10 PM
Study NCT ID:
NCT01258933
Status:
TERMINATED
Last Update Posted:
2025-10-01
First Post:
2010-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07-06
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-18
Completion Date Type:
ACTUAL
First Submit Date:
2010-12-09
First Submit QC Date:
None
Study First Post Date:
2010-12-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2025-09-12
Results First Submit QC Date:
None
Results First Post Date:
2025-10-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-12
Last Update Post Date:
2025-10-01
Last Update Post Date Type:
ESTIMATED